Papa’s Cheese Bar Founded in 2015 to Save Lives

Papa Foods, Inc. announced today that it is partnering with the University of Arizona to develop an innovative, scalable, and cost-effective way to detect papillomavirus infections.

The company will develop and commercialize a test, called Papa Scrub, that detects all known strains of the virus.

Papa has been developing PapaScrub for several years and has been working with the UA for more than a decade to develop and develop the technology. 

“We’re excited to have Papa come together with the Department of Pathology to help us achieve this goal,” said Dr. Jonathan K. Parson, the University’s president and CEO.

“It will give us an easy way to assess the health of patients, improve patient care, and improve the safety of our patients and patients’ families.” 

The test will be available to the public starting in the fall of 2019 and will cost $50 per sample, or $150 for a case.

The technology can detect the presence of the human papilloma virus in about 95% of people who have tested positive. 

The technology is the result of years of work by Dr. Parnia Ritchie, assistant professor of pathology at the University. 

In 2016, the UA, along with Dr. K.A. Wahlstrom and Dr. Michael B. Gannon, former chair of the UA’s Department of Biomedical Engineering and former head of the National Institutes of Health’s National Institute of Allergy and Infectious Diseases, funded the Papa research and clinical trial, which was sponsored by the National Institute on Aging, the National Heart, Lung and Blood Institute, and the American Heart Association. 

 “The partnership with the Arizona Health Sciences Center is a perfect fit for Papa, and we’re excited that we can partner with a leading research university to accelerate its development and deliver a groundbreaking technology that could save lives,” said Parnian. 

PapaScrubs work by detecting viral proteins called papilloviruses.

The virus is found in the small intestines and causes inflammation and pain. 

Scientists are using the technology to detect whether or not people are infected and to monitor the health status of people, such as heart disease, cancer, or autoimmune disease. 

Using the Papabubble app, people can also view the virus in the environment and take health surveys about their health. 

To help test the Papavirus, the university is partnering on a project called the Papal Virus Registry.

The Papabuble app will allow people to enter their social security number and the date they last tested positive for the virus, which will help determine if a person has a risk of getting the virus or is at risk of contracting it. 

This information will help Papabubs staff and volunteers make the Papapubbles, which the company hopes will be used to better track the spread of the disease.

The researchers hope the Papaduce will be the first test to test for the Papillomovirus in the U.S. in 2026. 

More than 10,000 people have died from the papilloms coronavirus. 

About 3.5 million people in the United States live with the disease and more than 50,000 have died. 

Dr. Kailani D. Bajaj, the lead author of the study and a postdoctoral researcher at the UA and the University, is a faculty member at the Department’s Center for Disease Control and Prevention. 

For more information about Papa Technologies, please visit